NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Universe Pharmaceuticals INC (NASDAQ: UPC)
UPC Technical Analysis
5
As on 24th Dec 2024 UPC STOCK Price closed @ 0.62 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.62 & Strong Sell for SHORT-TERM with Stoploss of 1.25 we also expect STOCK to react on Following IMPORTANT LEVELS. |
UPCSTOCK Price
Open | 0.62 | Change | Price | % |
High | 0.64 | 1 Day | -0.01 | -1.59 |
Low | 0.61 | 1 Week | -0.15 | -19.48 |
Close | 0.62 | 1 Month | 0.37 | 148.00 |
Volume | 96105 | 1 Year | 0.25 | 67.57 |
52 Week High 3.95 | 52 Week Low 0.14 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
LMDX | 0.02 | 0.00% |
LCID | 3.20 | 3.23% |
AVGR | 1.45 | 126.56% |
NVDA | 140.22 | 0.39% |
AKTS | 0.04 | 0.00% |
TNXP | 0.39 | -2.50% |
PONO | 1.72 | 2.38% |
TELL | 1.00 | 0.00% |
TSLA | 462.28 | 7.36% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
UPC Daily Charts |
UPC Intraday Charts |
Whats New @ Bazaartrend |
UPC Free Analysis |
|
UPC Important Levels Intraday
RESISTANCE | 0.68 |
RESISTANCE | 0.66 |
RESISTANCE | 0.65 |
RESISTANCE | 0.64 |
SUPPORT | 0.60 |
SUPPORT | 0.59 |
SUPPORT | 0.58 |
SUPPORT | 0.56 |
UPC Forecast December 2024
4th UP Forecast | 1.85 |
3rd UP Forecast | 1.46 |
2nd UP Forecast | 1.21 |
1st UP Forecast | 0.97 |
1st DOWN Forecast | 0.27 |
2nd DOWN Forecast | 0.03 |
3rd DOWN Forecast | -0.22 |
4th DOWN Forecast | -0.61 |
UPC Weekly Forecast
4th UP Forecast | 0.72 |
3rd UP Forecast | 0.69 |
2nd UP Forecast | 0.67 |
1st UP Forecast | 0.65 |
1st DOWN Forecast | 0.59 |
2nd DOWN Forecast | 0.57 |
3rd DOWN Forecast | 0.55 |
4th DOWN Forecast | 0.52 |
UPC Forecast2024
4th UP Forecast | 9.89 |
3rd UP Forecast | 6.92 |
2nd UP Forecast | 5.08 |
1st UP Forecast | 3.24 |
1st DOWN Forecast | -2 |
2nd DOWN Forecast | -3.84 |
3rd DOWN Forecast | -5.68 |
4th DOWN Forecast | -8.65 |
Universe Pharmaceuticals INC ( NASDAQ USA Symbol : UPC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
UPC Other Details
Segment | EQ | |
Market Capital | 49807500.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
UPC Address
UPC Latest News
UPC Business Profile
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief for common chronic health conditions in the elderly for the physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'an, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited. Address: No. 265, Jingjiu Avenue, Ji'an, China
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service